Benefit of pazopanib in advanced gastrointestinal stromal tumours: results from a phase II trial (SSG XXI, PAGIST)

Autor: Eriksson, M., Reichardt, P., Joensuu, H., Krarup-Hansen, A., Hagberg, O., Hohenberger, P., Hagberg, H., Hansson, L., Foukakis, T., Pulkkanen, K., Bauer, S., Goplen, D., Blach Rossen, P., Sundby Hall, K.

Publikováno v: In ESMO Open August 2021 6(4)

Survival of patients with ruptured gastrointestinal stromal tumour treated with adjuvant imatinib in a randomised trial.

Autor: Joensuu H; Department of Oncology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland. heikki.joensuu@hus.fi., Reichardt A; Helios Klinikum Berlin-Buch, and Berlin Medical School, Berlin, Germany., Eriksson M; Department of Oncology, Skåne University Hospital and Lund University, Lund, Sweden., Hohenberger P; Division of Surgical Oncology & Thoracic Surgery, Mannheim University Medical Center, Mannheim, Germany., Boye K; Department of Oncology, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway., Cameron S; Department of Gastroenterology and Gastrointestinal Oncology, University Medicine Göttingen, Göttingen, Germany., Lindner LH; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany., Jost PJ; Medical Department III, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.; Division of Clinical Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria., Bauer S; Department of Medical Oncology and Sarcoma Center, West German Cancer Center, University Duisburg-Essen, Medical School, Essen, Germany.; DKTK partner site Essen, German Cancer Consortium (DKTK), Heidelberg, Germany., Schütte J; Schwerpunktpraxis Oncology/ Hematology, Düsseldorf, Germany.; Universitätsklinikum Essen Innere Klinik Essen, Essen, Germany., Lindskog S; Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Department of Surgery, Halland Hospital, Varberg, Sweden., Kallio R; Department of Oncology and Radiotherapy, Oulu University Hospital, Oulu, Finland., Jaakkola PM; Department of Oncology, Turku University Hospital and University of Turku, Turku, Finland., Goplen D; Haukeland University Hospital, Bergen, Norway., Wardelmann E; Gerhard-Domagk-Institute of Pathology, University of Münster, Münster, Germany., Reichardt P; Helios Klinikum Berlin-Buch, and Berlin Medical School, Berlin, Germany.

Publikováno v: British journal of cancer [Br J Cancer] 2024 Jul; Vol. 131 (2), pp. 299-304. Date of Electronic Publication: 2024 Jun 11.

1785TiP PERELI, a phase II, open label, multicenter study of pemigatinib and retifanlimab in advanced dedifferentiated liposarcoma

Autor: Nyström, H., Pedersen, N.A., Junker, N., Papakonstantinou, A., Hansson, L., Goplen, D., Wesche, J., Carneiro, A., Boye, K.

Publikováno v: In Annals of Oncology September 2024 35 Supplement 2:S1060-S1060

Investigating survival, quality of life and cognition in PROton versus photon therapy for IDH- mutated diffuse grade 2 and 3 GLIOmas (PRO-GLIO): a randomised controlled trial in Norway and Sweden.

Autor: Heggebø LC; Department of Oncology, Oslo University Hospital, Oslo, Norway licahe@ous-hf.no.; Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Borgen IMH; Department of Oncology, Oslo University Hospital, Oslo, Norway.; Department of Physical Medicine and Rehabilitation, Oslo University Hospital, Oslo, Norway., Rylander H; Skandion Clinic, Uppsala, Sweden., Kiserud C; Department of Oncology, Oslo University Hospital, Oslo, Norway., Nordenmark TH; Department of Physical Medicine and Rehabilitation, Oslo University Hospital, Oslo, Norway.; Department of Psychology, Faculty of Social Sciences, University of Oslo, Oslo, Norway., Hellebust TP; Department of Medical Physics, Oslo University Hospital, Oslo, Norway.; Department of Physics, University of Oslo, Oslo, Norway., Evensen ME; Department of Oncology, Oslo University Hospital, Oslo, Norway.; Section of Oncology, Drammen Hospital, Drammen, Norway., Gustavsson M; Department of Medical Physics and Biomedical Engineering, Sahlgrenska University Hospital, Gothenburg, Sweden.; Department of Medical Radiation Science, Institute of Clinical Sciences, Sahlgrenska Academy, Gothenburg, Sweden., Ramberg C; Department of Medical Physics, Oslo University Hospital, Oslo, Norway., Sprauten M; Department of Oncology, Oslo University Hospital, Oslo, Norway., Magelssen H; Department of Oncology, Oslo University Hospital, Oslo, Norway., Blakstad H; Department of Oncology, Oslo University Hospital, Oslo, Norway.; Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Moorthy J; Department of Oncology, Oslo University Hospital, Oslo, Norway., Andersson K; Skandion Clinic, Uppsala, Sweden., Raunert I; Department of Medical Physics and Biomedical Engineering, Sahlgrenska University Hospital, Gothenburg, Sweden., Henry T; Department of Medical Physics and Biomedical Engineering, Sahlgrenska University Hospital, Gothenburg, Sweden.; Department of Medical Radiation Science, Institute of Clinical Sciences, Sahlgrenska Academy, Gothenburg, Sweden., Moe C; Department of Research Support for Clinical Trials, Oslo University Hospital, Oslo, Norway., Granlund C; Department of Oncology, Oslo University Hospital, Oslo, Norway., Goplen D; Department of Oncology and Medical Physics, Haukeland University Hospital, Bergen, Norway., Brekke J; Department of Oncology and Medical Physics, Haukeland University Hospital, Bergen, Norway., Johannessen TA; Department of Oncology and Medical Physics, Haukeland University Hospital, Bergen, Norway., Solheim TS; Cancer Clinic, St Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway., Marienhagen K; Department of Oncology, University Hospital of North Norway, Tromso, Norway., Humberset Ø; Department of Oncology, University Hospital of North Norway, Tromso, Norway., Bergström P; Department of Oncology, University Hospital of Umeå, Umeå, Sweden., Agrup M; Department of Oncology, Linköping University Hospital, Linköping, Sweden.; Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden., Dahl L; Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Lund, Sweden., Gubanski M; Department of Radiotherapy, Karolinska University Hospital, Stockholm, Sweden., Gojon H; Department of Radiotherapy, Karolinska University Hospital, Stockholm, Sweden., Brahme CJ; Skandion Clinic, Uppsala, Sweden., Rydén I; Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, University of Gothenburg, Sahlgrenska Academy, Gothenburg, Sweden., Jakola AS; Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, University of Gothenburg, Sahlgrenska Academy, Gothenburg, Sweden.; Department of Neurosurgery, Sahlgrenska University Hospital, Gothenburg, Sweden., Vik-Mo EO; Department of Neurosurgery, Oslo University Hospital, Oslo, Norway., Lie HC; Department of Behavioural Medicine, Institute of Basic Medical Sciences, Faculty of Medicine, University of Oslo, Oslo, Norway., Asphaug L; Department of Research Support for Clinical Trials, Oslo University Hospital, Oslo, Norway., Hervani M; Department of Oncology, Oslo University Hospital, Oslo, Norway., Kristensen I; Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Lund, Sweden., Rueegg CS; Oslo Centre for Biostatistics and Epidemiology, Oslo University Hospital, Oslo, Norway., Olsen IC; Department of Research Support for Clinical Trials, Oslo University Hospital, Oslo, Norway., Ledal RJ; Norwegian Brain Tumor Alliance, Oslo, Norway., Degsell E; Swedish Brain Tumor Association, Stockholm, Sweden., Werlenius K; Department of Oncology, Sahlgrenska University Hospital, Gothenburg, Sweden.; Department of Oncology, Institute of Clinical Sciences, University of Gothenburg, Sahlgrenska Academy, Gothenburg, Sweden., Blomstrand M; Department of Oncology, Sahlgrenska University Hospital, Gothenburg, Sweden.; Department of Oncology, Institute of Clinical Sciences, University of Gothenburg, Sahlgrenska Academy, Gothenburg, Sweden., Brandal P; Department of Oncology, Oslo University Hospital, Oslo, Norway.; Institute for Cancer Genetics and Informatics, Oslo University Hospital, Oslo, Norway.

Publikováno v: BMJ open [BMJ Open] 2023 Mar 20; Vol. 13 (3), pp. e070071. Date of Electronic Publication: 2023 Mar 20.

Survival in a consecutive series of 467 glioblastoma patients: Association with prognostic factors and treatment at recurrence at two independent institutions.

Autor: Blakstad H; Department of Oncology, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.; Institute for Clinical Medicine, University of Oslo, Oslo, Norway., Brekke J; Department of Oncology and Medical Physics, Haukeland University Hospital, Bergen, Norway., Rahman MA; Department of Oncology and Medical Physics, Haukeland University Hospital, Bergen, Norway.; Institute for Biomedicine, University of Bergen, Bergen, Norway., Arnesen VS; Department of Oncology and Medical Physics, Haukeland University Hospital, Bergen, Norway.; Institute for Biomedicine, University of Bergen, Bergen, Norway., Miletic H; Institute for Biomedicine, University of Bergen, Bergen, Norway.; Department of Pathology, Haukeland University Hospital, Bergen, Norway., Brandal P; Department of Oncology, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.; Institute for Cancer Genetics and Informatics, Oslo University Hospital, Oslo, Norway., Lie SA; Institute for Clinical Dentistry, University of Bergen, Bergen, Norway., Chekenya M; Institute for Biomedicine, University of Bergen, Bergen, Norway., Goplen D; Department of Oncology and Medical Physics, Haukeland University Hospital, Bergen, Norway.

Publikováno v: PloS one [PLoS One] 2023 Feb 02; Vol. 18 (2), pp. e0281166. Date of Electronic Publication: 2023 Feb 02 (Print Publication: 2023).